Search
Structural determinants of long term functional outcomes in young children with cystic fibrosis BACKGROUND: Accelerated lung function decline in
Development and validation of a miniaturized bacteriophage host range screening assay against antibiotic resistant Pseudomonas aeruginosa
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases Antisense oligonucleotides (AOs) are an emerging
News & Events
MRCF launches Perth-based biotech developing new treatment for Cystic FibrosisA The Kids Research Institute Australia spin-off company has received $20 million from the Medical Research Commercialisation Fund to develop a promising new therapy for the treatment of Cystic Fibrosis.
Sialic acid-to-urea ratio as a measure of airway surface hydration. Although airway mucus dehydration is key to pathophysiology of cystic fibrosis (CF
Multiple Breath Washout Cannot Be Used for Tidal Breath Parameter Analysis in Infants Background: Multiple breath washout (MBW) testing with SF6 gas
Hypoxia and sterile inflammation in cystic fibrosis airways mechanisms and potential therapies ABSTRACT Cystic fibrosis is one of the most common
Lack of small colony variants of Staphylococcus aureus from lower respiratory tract specimens Abstract Background: Small-colony variants (SCVs) of
Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis The solute carrier family 6 member 14 (
The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis Lung inflammation and infection are common